Dr. Hakan Ismail Sari
Senior Consultant Hematology
Memorial Atasehir HospitalIstanbul, Turchia
25+ anni di esperienza
A proposito di dottore
Titolo di studio:
- MD in Medicina Interna
- Specialist in Hematology
Panoramica:
Prof. Dr. Hakan Ismail Sari is a distinguished hematologist with a profound impact on the field of blood diseases. Currently serving at Memorial Atasehir Hospital in Istanbul, he brings over 25 years of experience in diagnosing and treating complex hematological conditions.
His medical journey commenced with a specialization in internal medicine, followed by a focus on hematology. He has held significant positions, including:
- Hematology Specialist and Deputy Chief Physician at Golcuk Military Hospital (2006–2015)
- Hematology and Internal Medicine Specialist at Erciyes University (1998–2006)
Beyond his clinical roles, Prof. Dr. Sari contributes to the academic community as an Editorial Board Member of the journal "Transfusion and Apheresis Science" and serves as an educator, shaping future medical professionals
His commitment to patient care, combined with his academic contributions, underscores his reputation as a leading figure in hematology.
Condizioni trattate
- Leucemia
- Linfoma
- Mieloma multiplo
- Anemia
- Trombocitopenia
- Emofilia
- Sindromi mielodisplastiche
- Anemia aplastica
- Policitemia vera
- Talassemia
Procedure eseguite
- Biopsia del midollo osseo
- Chemioterapia per le neoplasie ematologiche
- Trapianto di cellule staminali
- Aferesi
- immunoterapia
- Terapia mirata
- Gestione dei disturbi emorragici
- Terapia trasfusionale del sangue
Invia la tua richiesta di trattamento
Domande Frequenti
He is proficient in English and Turkish, facilitating communication with international patients.
Appointments can be arranged directly through Memorial Atasehir Hospital. Alternatively, HOSPIDIO offers assistance in booking consultations. Contact us at [email protected] or via Call/WhatsApp at +91-9870538337 for support.
Yes, online consultations are available. Please reach out to HOSPIDIO to coordinate virtual appointments.
He employs a patient-centric approach, integrating the latest advancements in hematology to devise personalized treatment plans.
Yes, he actively contributes to medical research and serves on the editorial board of "Transfusion and Apheresis Science," reflecting his commitment to advancing the field